Product Name | NebuSelect™ Recombinant Biotinylated Human SLAMF7/CRACC/CD319, Avi-His-tag |
---|---|
Catalog Number | NBL-240972 |
Alias/Synonyms | SLAMF7/CRACC/CD319; CD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12 |
Appearance | see COA |
Molecule Weight | Ser23-Met226 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | Q9NQ25-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240972-100ug | 100ug | Inquire | Inquire | |
NBL-240972-1mg | 1mg | Inquire | Inquire | |
NBL-240972-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human SLAMF7/CRACC/CD319, Avi-His-tag
Catalog#:
NBL-240972
Description:
NebuSelect™ Recombinant Biotinylated Human SLAMF7/CRACC/CD319, Avi-His-tag(Cat#NBL-240972) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Ser23-Met226
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 25.3 kDa. Due to glycosylation, the protein migrates to 40-60 kDa based on Bis-Tris PAGE result.
Target Name:
SLAMF7/CRACC/CD319; CD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12
Target Information:
CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.
Amino Acid Sequence:
Ser23-Met226
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.